Shanghai/Shenzhen Connect Ideas: Ping An & Wuxi Apptec (2019-07-05)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
517 Views
Hansoh Pharma (翰森制药) Post-IPO Trading Update: Fairly Valued
Hansoh Pharma's IPO was priced at the high end and started trading last Friday. In our earlier note, we argued that the company should trade at...
559 Views
Jinxin Fertility Group IPO: 4Q Update Is Good but Is It Sustainable?
Jinxin Fertility Co Ltd (1951 HK) is a leading assisted reproductive service (ARS) provider in China and the US. Its network of ARS medical...
869 Views
Jinxin Fertility (锦欣生殖) IPO - Worth a Look Given the Sector, Existing Shareholders and Cornerstone
Jinxin Fertility Co Ltd (1659778D CH) plans to raise up to US$390m in its Hong Kong IPO. Ke Yan, CFA, FRM has covered most details of the company...
875 Views
Jinxin Fertility Group IPO Preview: Baby Boom or Bust?
Jinxin Fertility Co Ltd (1659778D CH) is a leading assisted reproductive service (ARS) provider in China and the US. Its network of ARS medical...
943 Views